vs

Side-by-side financial comparison of Core & Main, Inc. (CNM) and Edwards Lifesciences (EW). Click either name above to swap in a different company.

Core & Main, Inc. is the larger business by last-quarter revenue ($2.1B vs $1.6B, roughly 1.3× Edwards Lifesciences). Edwards Lifesciences runs the higher net margin — 23.1% vs 6.6%, a 16.4% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 0.0%). Over the past eight quarters, Core & Main, Inc.'s revenue compounded faster (19.7% CAGR vs 9.7%).

Core & Main, headquartered in St. Louis, Missouri, distributes products used for water, wastewater, storm drainage, and fire protection in the United States. Customers include municipalities, private water companies, and professional contractors. The company has 370 branch locations in 49 U.S. states, 60,000 customers, and sells 225,000 products.

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

CNM vs EW — Head-to-Head

Bigger by revenue
CNM
CNM
1.3× larger
CNM
$2.1B
$1.6B
EW
Growing faster (revenue YoY)
EW
EW
+16.7% gap
EW
16.7%
0.0%
CNM
Higher net margin
EW
EW
16.4% more per $
EW
23.1%
6.6%
CNM
Faster 2-yr revenue CAGR
CNM
CNM
Annualised
CNM
19.7%
9.7%
EW

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CNM
CNM
EW
EW
Revenue
$2.1B
$1.6B
Net Profit
$137.0M
$380.7M
Gross Margin
27.2%
78.0%
Operating Margin
10.7%
1.8%
Net Margin
6.6%
23.1%
Revenue YoY
0.0%
16.7%
Net Profit YoY
0.0%
6.8%
EPS (diluted)
$0.72
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNM
CNM
EW
EW
Q1 26
$1.6B
Q4 25
$2.1B
$1.6B
Q3 25
$2.1B
$1.6B
Q2 25
$1.9B
$1.5B
Q1 25
$1.7B
$1.4B
Q4 24
$2.0B
$1.4B
Q3 24
$2.0B
$1.4B
Q2 24
$1.7B
$1.4B
Net Profit
CNM
CNM
EW
EW
Q1 26
$380.7M
Q4 25
$137.0M
$91.2M
Q3 25
$134.0M
$291.1M
Q2 25
$100.0M
$333.2M
Q1 25
$64.0M
$358.0M
Q4 24
$133.0M
$385.6M
Q3 24
$119.0M
$3.1B
Q2 24
$95.0M
$366.3M
Gross Margin
CNM
CNM
EW
EW
Q1 26
78.0%
Q4 25
27.2%
78.1%
Q3 25
26.8%
77.8%
Q2 25
26.7%
77.5%
Q1 25
26.6%
78.7%
Q4 24
26.6%
78.9%
Q3 24
26.4%
80.6%
Q2 24
26.9%
79.9%
Operating Margin
CNM
CNM
EW
EW
Q1 26
1.8%
Q4 25
10.7%
9.6%
Q3 25
10.2%
19.8%
Q2 25
8.9%
26.8%
Q1 25
7.3%
27.9%
Q4 24
10.9%
22.6%
Q3 24
10.4%
25.9%
Q2 24
9.6%
26.8%
Net Margin
CNM
CNM
EW
EW
Q1 26
23.1%
Q4 25
6.6%
5.8%
Q3 25
6.4%
18.7%
Q2 25
5.2%
21.7%
Q1 25
3.8%
25.3%
Q4 24
6.5%
27.8%
Q3 24
6.1%
226.7%
Q2 24
5.5%
26.7%
EPS (diluted)
CNM
CNM
EW
EW
Q1 26
$0.66
Q4 25
$0.72
$0.16
Q3 25
$0.70
$0.50
Q2 25
$0.52
$0.56
Q1 25
$0.34
$0.61
Q4 24
$0.69
$0.65
Q3 24
$0.61
$5.13
Q2 24
$0.49
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNM
CNM
EW
EW
Cash + ST InvestmentsLiquidity on hand
$89.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.0B
Total Assets
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNM
CNM
EW
EW
Q1 26
Q4 25
$89.0M
$4.2B
Q3 25
$25.0M
$3.8B
Q2 25
$8.0M
$4.1B
Q1 25
$8.0M
$3.9B
Q4 24
$10.0M
$4.0B
Q3 24
$13.0M
$4.4B
Q2 24
$30.0M
$2.0B
Stockholders' Equity
CNM
CNM
EW
EW
Q1 26
Q4 25
$2.0B
$10.3B
Q3 25
$1.9B
$10.2B
Q2 25
$1.7B
$10.5B
Q1 25
$1.7B
$10.1B
Q4 24
$1.7B
$10.0B
Q3 24
$1.6B
$9.5B
Q2 24
$1.6B
$7.4B
Total Assets
CNM
CNM
EW
EW
Q1 26
Q4 25
$6.3B
$13.7B
Q3 25
$6.3B
$13.3B
Q2 25
$6.3B
$13.5B
Q1 25
$5.9B
$13.0B
Q4 24
$6.2B
$13.1B
Q3 24
$6.1B
$13.0B
Q2 24
$6.0B
$10.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNM
CNM
EW
EW
Operating Cash FlowLast quarter
$271.0M
Free Cash FlowOCF − Capex
$263.0M
FCF MarginFCF / Revenue
12.8%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.98×
TTM Free Cash FlowTrailing 4 quarters
$575.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNM
CNM
EW
EW
Q1 26
Q4 25
$271.0M
$450.9M
Q3 25
$34.0M
$573.7M
Q2 25
$77.0M
$290.2M
Q1 25
$235.0M
$280.4M
Q4 24
$260.0M
$-127.5M
Q3 24
$48.0M
$351.8M
Q2 24
$78.0M
$371.5M
Free Cash Flow
CNM
CNM
EW
EW
Q1 26
Q4 25
$263.0M
$353.5M
Q3 25
$24.0M
$516.2M
Q2 25
$64.0M
$240.9M
Q1 25
$224.0M
$224.4M
Q4 24
$252.0M
$-177.3M
Q3 24
$39.0M
$299.9M
Q2 24
$71.0M
$286.1M
FCF Margin
CNM
CNM
EW
EW
Q1 26
Q4 25
12.8%
22.5%
Q3 25
1.1%
33.2%
Q2 25
3.3%
15.7%
Q1 25
13.2%
15.9%
Q4 24
12.4%
-12.8%
Q3 24
2.0%
22.1%
Q2 24
4.1%
20.9%
Capex Intensity
CNM
CNM
EW
EW
Q1 26
Q4 25
0.4%
6.2%
Q3 25
0.5%
3.7%
Q2 25
0.7%
3.2%
Q1 25
0.6%
4.0%
Q4 24
0.4%
3.6%
Q3 24
0.5%
3.8%
Q2 24
0.4%
6.2%
Cash Conversion
CNM
CNM
EW
EW
Q1 26
Q4 25
1.98×
4.94×
Q3 25
0.25×
1.97×
Q2 25
0.77×
0.87×
Q1 25
3.67×
0.78×
Q4 24
1.95×
-0.33×
Q3 24
0.40×
0.11×
Q2 24
0.82×
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNM
CNM

Pipes Valves And Fitting Products$1.4B67%
Storm Drainage Products$333.0M16%
Meter Products$195.0M9%
Fire Protection Products$152.0M7%

EW
EW

Segment breakdown not available.

Related Comparisons